Literature DB >> 26654688

Deployment stress, tobacco use, and postdeployment posttraumatic stress disorder: Gender differences.

Sandra J Japuntich1, Kristin Gregor1, Suzanne L Pineles1, Jaimie L Gradus1, Amy E Street1, Rao Prabhala2, Ann M Rasmusson1.   

Abstract

OBJECTIVE: Epidemiological research has demonstrated that tobacco use and posttraumatic stress disorder (PTSD) frequently co-occur and are highly prevalent among Veterans; research with female Veterans is limited. Given the increasing numbers of women deployed to combat zones in recent conflicts, the objective of the current study was to examine gender-specific associations between deployment stress, tobacco use and postdeployment PTSD symptoms.
METHOD: Two thousand thirteen Veterans deployed to Afghanistan and Iraq (50.9% female; mean age = 35.53) completed a postdeployment, mailed survey that assessed tobacco use before, during, and after deployment, deployment stressors, and postdeployment PTSD symptoms.
RESULTS: Warfare stress was associated with initiation and increases in tobacco use during deployment in both men and women, whereas harassment stress was associated with initiation and increases in tobacco use in women only. Only among women was continued postdeployment tobacco use associated with postdeployment PTSD symptoms.
CONCLUSIONS: We found a dose-dependent relationship between deployment stress and adoption and escalation of tobacco use; the stressors that provoked initiation and escalation of tobacco use differed by gender. Continued tobacco use after deployment was associated with PTSD in women suggesting that women used tobacco more selectively than men to regulate negative affect. Implications of this work are that training before combat and during combat on healthy means of coping with deployment stress is needed to prevent tobacco use. For women, reducing harassment stress during deployment and early treatment of acute stress and PTSD during and soon after deployment may prevent intractable tobacco use. (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 26654688     DOI: 10.1037/tra0000093

Source DB:  PubMed          Journal:  Psychol Trauma        ISSN: 1942-969X


  5 in total

1.  The search for individualized smoking cessation therapy.

Authors:  Ilka Lopes Santoro
Journal:  J Bras Pneumol       Date:  2017 Jan-Feb       Impact factor: 2.624

Review 2.  Neurotransmitter, Peptide, and Steroid Hormone Abnormalities in PTSD: Biological Endophenotypes Relevant to Treatment.

Authors:  Ann M Rasmusson; Suzanne L Pineles
Journal:  Curr Psychiatry Rep       Date:  2018-07-17       Impact factor: 5.285

3.  Tobacco dependence is associated with increased risk for multi-morbid clustering of posttraumatic stress disorder, depressive disorder, and pain among post-9/11 deployed veterans.

Authors:  Jennifer R Fonda; Kristin L Gregor; Catherine B Fortier; Erica R Scioli-Salter; Regina E McGlinchey; Ann Rasmusson
Journal:  Psychopharmacology (Berl)       Date:  2019-01-07       Impact factor: 4.530

4.  Sweat pore reactivity as a surrogate measure of sympathetic nervous system activity in trauma-exposed individuals with and without posttraumatic stress disorder.

Authors:  Babajide O Familoni; Kristin L Gregor; Thomas S Dodson; Alan T Krzywicki; Bobby N Lowery; Scott P Orr; Michael K Suvak; Ann M Rasmusson
Journal:  Psychophysiology       Date:  2016-06-11       Impact factor: 4.348

5.  Cross-lagged effects of posttraumatic stress disorder symptom severity and cigarette smoking among OEF/OIF/OND veterans.

Authors:  Colin T Mahoney; Ilana R Zweig; Brian P Marx; Terence M Keane
Journal:  Depress Anxiety       Date:  2020-08-26       Impact factor: 8.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.